COMPARISON OF FIRST-LINE TREATMENT WITH CHOP VERSUS ICED IN PATIENTS WITH PERIPHERAL T-CELL LYMPHOMA ELIGIBLE FOR UPFRONT AUTOLOGOUS STEM CELL TRANSPLANTATION

Comparison of first-line treatment with CHOP versus ICED in patients with peripheral T-cell lymphoma eligible for upfront autologous stem cell transplantation

IntroductionUpfront autologous stem cell transplantation (ASCT) has been Soft Doll recommended for patients who are newly diagnosed with peripheral T-cell lymphoma (PTCL), and CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone), an anthracycline-based chemotherapy has been the frontline chemotherapy for PTCL.However, it is not clear w

read more